Literature DB >> 29118752

Role of the Human Breast Milk-Associated Microbiota on the Newborns' Immune System: A Mini Review.

Marco Toscano1, Roberta De Grandi1, Enzo Grossi2, Lorenzo Drago1,3.   

Abstract

The human milk is fundamental for a correct development of newborns, as it is a source not only of vitamins and nutrients, but also of commensal bacteria. The microbiota associated to the human breast milk contributes to create the "initial" intestinal microbiota of infants, having also a pivotal role in modulating and influencing the newborns' immune system. Indeed, the transient gut microbiota is responsible for the initial change from an intrauterine Th2 prevailing response to a Th1/Th2 balanced one. Bacteria located in both colostrum and mature milk can stimulate the anti-inflammatory response, by stimulating the production of specific cytokines, reducing the risk of developing a broad range of inflammatory diseases and preventing the expression of immune-mediated pathologies, such as asthma and atopic dermatitis. The aim of the present Mini Review is to elucidate the specific immunologic role of the human milk-associated microbiota and its impact on the newborn's health and life, highlighting the importance to properly study the biological interactions in a bacterial population and between the microbiota and the host. The Auto Contractive Map, for instance, is a promising analytical methodology based on artificial neural network that can elucidate the specific role of bacteria contained in the breast milk in modulating the infants' immunological response.

Entities:  

Keywords:  AutoCM; colostrum; human milk; immunomodulation; milk microbiota; newborn’s immune system

Year:  2017        PMID: 29118752      PMCID: PMC5661030          DOI: 10.3389/fmicb.2017.02100

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


Introduction

The human milk is a rich and complete nourishment that is essential for the correct development of the infant’s organism (Ballard and Morrow, 2013). The first milk produced by mothers after the delivery is called colostrum and it is biochemically and functionally different from the mature milk (Castellote et al., 2011). Colostrum, indeed, contains high concentration of lactoferrin, Immunoglobulin A (IgA), leukocytes and specific developmental factors, and a low amount of lactose, potassium and calcium, underlying its immunological functions rather than nutritional (Kulski and Hartmann, 1981; Pang and Hartmann, 2007). From 5 days to 2 weeks postpartum, there is the production of transitional milk which shares some characteristics of colostrum, although its main function is to support newborns at nutritional level (Henderson et al., 2008; Nommsen-Rivers et al., 2012). Finally, 2 weeks after the delivery the milk can be considered as mature and its composition tends to be stable over the time, even if slight variations can occur during lactation (Ballard and Morrow, 2013). The main components of human milk are: (i) macronutrients, such as protein, fat and lactose, which concentration depends on the stage of lactation and maternal characteristics; (ii) micronutrients, including vitamins A, B1, B2, B12 and D that vary in human milk in relation to maternal diet and body stores; (iii) growth factor, which are strongly active on the endocrine system, nervous system, vasculature and intestinal tract; (iv) immunological factors, which are essential to defend the newborn from inflammation and infection, and for this reason, the early milk is rich in immune components that can support infants in the first delicate stages of their life; (v) the microbiota, which comprises more than 200 different bacterial species with a pivotal role in the formation of the newborn’s first gut microbiota (Drago et al., 2017). The aim of the present Mini Review is to highlight the specific and fundamental role of human milk-associated bacteria in modulating and influencing the newborns’ immune system during their life.

The Milk Microbiota and the Newborn’S Immune System

The specific mechanisms that lead to the formation of the human milk microbiota are still unknown; however, there are different hypothesis that can explain the origin of milk-associated bacteria. Indeed, some microorganisms belonging to the maternal skin or infant’s oral cavity may become an integral component of the milk microbiota by means of a milk flow back into mammary ducts during lactation (Rodríguez, 2014). This mechanism may justify the presence of cutaneous and oral bacteria that are recovered in the milk microbiota, such as Streptococcus spp. and Staphylococcus spp. (Gao et al., 2007; Grice et al., 2009). Interestingly, human milk contained also a great number of intestinal bacteria, which may spread from the maternal intestinal environment by a mechanism involving dendritic cells (DCs) and CD18+ cells (Rodríguez, 2014); these cellular types would be able to capture intestinal microorganisms from the gut lumen and transfer them to lactating mammary glands by means of translocation, which results to be increased during late pregnancy and lactation (Rodríguez, 2014). Consequently, the milk microbiota can shape the initial intestinal microbiome of newborns, together with the maternal intestinal and vaginal microorganisms that are ingested by the neonate during the passage through the birth canal (Houghteling and Walker, 2015). Human milk can stimulate the proliferation of numerous Bifidobacterium and Lactobacillus strains, the main probiotic microorganisms present in the gut, creating an acidic environmental rich in short chain fatty acids (SCFAs) with a protective and nutritive role at intestinal level (Bode, 2012; Walker and Iyengar, 2015). The constant intake, during lactation, of bacteria contained in the human milk leads to the formation of a transient intestinal microbiota that deeply impacts on the newborn’s development, acting mainly on the maturation of his immune system (Houghteling and Walker, 2015). Indeed, several studies underscored the strict link between the gut microbiota signals, the mucosal host defense and the maturation of immune system, both at intestinal and systemic level (Smith et al., 2007; Sekirov et al., 2008; Walker and Iyengar, 2015). It has been showed that an altered colonization of newborns’ gut may lead to a persistent intestinal dysbiosis and, consequently, to immune-mediated and metabolic diseases during infancy and childhood (Gareau et al., 2010; Johnson and Versalovic, 2012). Moreover, breast-fed newborns have shown to possess a more stable intestinal bacterial population and a well-balanced mucosal immune response if compared to the formula-fed ones (Gronlund et al., 2000; Bezirtzoglou et al., 2011); indeed, a healthy intestinal microbiota can induce specific T cell responses and modulate substrates oxidation, decreasing the impact of autoimmune and allergic diseases not only during childhood but also in adulthood (Guaraldi and Salvatori, 2012; Palma et al., 2012). Finally, breastfeeding has been observed to have a protective role against respiratory and gastrointestinal infections between the ages of 7 and 12 months, leading to a general improvement of symptoms associated to gastrointestinal infections (Duijts et al., 2010). Intestinal bacteria can also stimulate lymphoid elements and positively influence the maturation of both innate and adaptive immune system, as clearly demonstrated by studying germ-free animals (Cash and Hooper, 2005). It has been shown that in germ-free mice the villus capillaries develop poorly during weaning and remained in this condition also during adulthood, suggesting that the intestinal microbiota is fundamental for intestinal blood vessel to be completely developed (Martin et al., 2010). More interestingly, intestinal bacteria can promote B cell development in Peyer’s Patches and increase the production of mucosal IgA, the main antibody class in secretions that acts as first line of defense (Martin et al., 2010). Moreover, bacterial surface-expressed or secreted ligands can interact with specific receptors on mucosal immune system and enterocytes leading to a self-limited inflammatory response for preventing pathogen mucosal penetration (Round and Mazmanian, 2009; Walker and Iyengar, 2015). As underlined by Latuga et al. (2014), all newborns have an immature immune system and the cord blood rich in anti-inflammatory T regulatory cells; furthermore, infants have a high T helper 2 (Th2) that promotes humoral immunity with the production of IL4, IL6 and IL21, thus promoting an increased B cell response and, potentially, a higher allergic sensitization (Latuga et al., 2014). The pivotal role of milk-associated microbiota in influencing the neonates’ immune system is over-emphasized by the cytotoxic function promoted by microbial ligands in breast milk (Donnet-Hughes, 2008). Indeed, in vitro stimulation of DCs with lipopolysaccharide can lead to T-cells differentiation, supporting the hypothesis that mature milk may implement the maturation of cytotoxic Th1 cells and improve their activity against infections (M’Rabet et al., 2008). Probably, commensal colonic bacteria may stimulate the release of specific cytokines that create a balanced microenvironment suitable for naive Th0 cells to ripen toward Th1 cell type (Walker and Iyengar, 2015). Bacteroides is a bacterial genus that is very abundant in human colostrum and it may have a main role in the early stages of newborns’ gut colonization, as reported by Mazmanian and Kasper (2006). In particular, the polysaccharide A located on the surface of Bacteroides fragilis can interact with Toll receptor 2 on intestinal DCs to stimulate cytokine production which, in turn, favor the proliferation of FOXP3 T cells in the lamina propria. FOXP3 belongs to the forhead transcription factor family bindweed in the expansion of regulatory T cells, thus having a suppressive role in the host’s immune system (Kim, 2009). Therefore, it is clear that a correct stimulation of neonates’ intestinal environment is fundamental for the physiological development of mucosal immune system and tolerance; the latter, in particular, is extremely important to avoid developing allergy or autoimmune diseases (Walker and Iyengar, 2015). Indeed, germ-free animals cannot develop tolerance due to the lack of intestinal bacteria and only the adequate colonization of newborns’ gut can lead to a complete tolerance generation (Karlsson et al., 1999; Olszak et al., 2012). Consequently, breastfeeding is essential for oral tolerance in newborns, as it is extremely important for the establishment of local and systemic immune tolerance to antigens ingested during lactation (Verhasselt, 2010). Infants are daily exposed to specific antigens, part of which belong directly to the human milk microbiota, and that can translocate across the intestinal barrier, being involved in the presentation by antigen-presenting cells to T lymphocytes. Furthermore, bacteria located in the human milk are fundamental to correctly stimulate the Peyer’s patches, increasing the number of IgA-producing plasma cells in the intestinal environment of newborns (Gross, 2007). Consequently, IgA can trap food antigens favoring their elimination by specific enzymes, avoid the adherence of viruses and microorganisms to intestinal mucosa also counteracting the proliferation of pathogens and exert a direct immunomodulatory activity (Verhasselt, 2010). Finally, the oral tolerance seems to be actively involved in the prevention of allergic diseases onset in babies, avoiding also the impact of respiratory and gastrointestinal infections during the early stages of their life (Lack, 2008). Interestingly, some strains contained in the breast milk can stimulate immune responses in both animal and human models and their activity seems to have a moderate suppleness based on the gut environment (Fernández et al., 2013). Some Lactobacillus strains can enhance the production of Th1 cytokines as well as TNF-alpha even without inflammatory stimuli and activate NK cells, CD4+ and CD8+ T cells and regulatory T cells. Table summarizes the main immunomodulatory activities of human milk microbiota. Immunomodulatory activities of the human milk microbiota.

Microbial Network: New Insights Into Bacterial Ecology

The study of microbial interactions within a bacterial population is of extreme importance to clearly understand the specific role of microbiome. Indeed, microorganisms compete for nutrients, exchange genetic material and metabolites, being responsible of influencing the microbiota composition and the host’s health (Layeghifard et al., 2017). Due to its dynamic nature and high heterogeneity, the microbiota can be considered a complex and variable ecosystem not often well understandable. For this reason, in the last years a novel approach has been developed to study the microbiota, by using graph-theoretical, systems-oriented method able to facilitate the understanding of evolutionary and complex ecological processes (Layeghifard et al., 2017). Bacterial network is becoming essential to study microbial relationships and clarify the impact of various interactions on the host by identifying the main “hubs” that may represent the most influential member in a bacterial community (Layeghifard et al., 2017). Moreover, a central node is thought to have more links with other hubs, having a pivotal role in the stability of the whole microbial network. Numerous methods to identify network hubs exist, but in the last years there was a great interest in using and apply the Auto-Contractive map (AutoCM). AutoCM system is a fourth-generation unsupervised artificial neural network (ANN) that can outperform numerous unsupervised algorithms (Buscema and Sacco, 2016). The system uses the minimum spanning tree (MST) theory to underline the natural connections between variables (Buscema and Grossi, 2008; Buscema et al., 2008). A MST is a spanning tree of a connected, undirected graph that links all vertices together with the minimal total pondering for its edges. The concept is that as all biological and natural systems are inclined to a minimal energetic condition, the graph delineates the essential biological information of this process. The final goal of this approach is finding out all specific correlations between variables, creating a semantic map of connections in which non-linear associations are maintained. This approach allows to both highlight the relevant nodes of the system and show the network of the main relations among variables. Nodes, also defined as “hubs,” are defined as variables with the highest number of relations in the map (Buscema and Grossi, 2008; Buscema et al., 2008; Buscema and Sacco, 2016). AutoCM has already been used in the microbiological field to study the bacterial network of human colostrum and mature milk in Italian and Burundian populations, highlighting the main microbial hubs that represent the biological leading structure of the whole network (Drago et al., 2017). This mathematical approach could partially clarify the complexity of human-bacteria mutualism, and above all the role that some specific microorganisms have in the human milk. Figure shows a graphical representation of the human mature milk microbiota network obtained using AutoCM. The main bacterial hubs (blue lines) represent those microorganisms that may have a pivotal and leader role in the whole microbiota (Drago et al., 2017). Microbiota network of Italian mature milk. The figure shows the distribution of bacterial population contained in the Italian human mature milk. The network was obtained applying the AutoCM. The main hubs of the bacterial network are underlined with a blue line; red circle shows the central node of the network (Drago et al., 2017). As authors of the previously published manuscript, we maintain the ownership of copyright as stated in the license-to-publish we signed for the Nature Publishing Group. In the future, the AutoCM may be useful in understanding which microbe is directly involved in the stimulation and manipulation of newborns’ immune system, maybe defining a “immunomodulatory bacterial pattern” with a pivotal role in the development of infant’s immunity.

Conclusion

The human milk microbiota seems to have a central role in stimulate newborns’ immune system, contributing to create the first transient intestinal microbiota with strong immunomodulatory activities. However, further studies are needed to highlight the direct and strong connection between the human milk microbiota and the stimulation of newborns’ immune system, as to date there are no clear and specific evidence about this association. Application of network biology will significantly improve our knowledge on bacterial interactions among the milk microbiota, with important applications for eventual targeted modification of bacterial composition, aimed to enhance the abundance of those microorganisms that may be essential not only for the modulation of the infants’ immune system, but also for improving the whole host’s health.

Author Contributions

LD provided the general concept. LD and EG drafted part of the manuscript. MT and RDG wrote the manuscript. All authors revised and approved the manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Table 1

Immunomodulatory activities of the human milk microbiota.

Immunological activityReference
Maturation of local and systemic immune systemHoughteling and Walker, 2015
Implementation of mucosal newborns’ defenseSmith et al., 2007; Sekirov et al., 2008
Stimulation of specific cytokines that create a balanced microenvironmentWalker and Iyengar, 2015
Correct development of B cellsMartin et al., 2010
Stimulation of cytotoxic Th1 cellsM’Rabet et al., 2008
Correct balancing between Th1 and Th2 responseWalker and Iyengar, 2015
Development of oral toleranceVerhasselt, 2010
Stimulation of Peyer’s patchesGross, 2007
  37 in total

1.  Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy.

Authors:  Liesbeth Duijts; Vincent W V Jaddoe; Albert Hofman; Henriëtte A Moll
Journal:  Pediatrics       Date:  2010-06-21       Impact factor: 7.124

2.  Molecular analysis of human forearm superficial skin bacterial biota.

Authors:  Zhan Gao; Chi-hong Tseng; Zhiheng Pei; Martin J Blaser
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-09       Impact factor: 11.205

Review 3.  Breast-feeding and its role in early development of the immune system in infants: consequences for health later in life.

Authors:  Laura M'Rabet; Arjen Paul Vos; Günther Boehm; Johan Garssen
Journal:  J Nutr       Date:  2008-09       Impact factor: 4.798

4.  Timing of stage II lactogenesis is predicted by antenatal metabolic health in a cohort of primiparas.

Authors:  Laurie A Nommsen-Rivers; Lawrence M Dolan; Bin Huang
Journal:  Breastfeed Med       Date:  2011-04-27       Impact factor: 1.817

5.  Microbial exposure during early life has persistent effects on natural killer T cell function.

Authors:  Torsten Olszak; Dingding An; Sebastian Zeissig; Miguel Pinilla Vera; Julia Richter; Andre Franke; Jonathan N Glickman; Reiner Siebert; Rebecca M Baron; Dennis L Kasper; Richard S Blumberg
Journal:  Science       Date:  2012-03-22       Impact factor: 47.728

Review 6.  The love-hate relationship between bacterial polysaccharides and the host immune system.

Authors:  Sarkis K Mazmanian; Dennis L Kasper
Journal:  Nat Rev Immunol       Date:  2006-10-06       Impact factor: 53.106

Review 7.  The human milk microbiota: origin and potential roles in health and disease.

Authors:  Leónides Fernández; Susana Langa; Virginia Martín; Antonio Maldonado; Esther Jiménez; Rocío Martín; Juan M Rodríguez
Journal:  Pharmacol Res       Date:  2012-09-10       Impact factor: 7.658

Review 8.  Human milk oligosaccharides: every baby needs a sugar mama.

Authors:  Lars Bode
Journal:  Glycobiology       Date:  2012-04-18       Impact factor: 4.313

Review 9.  Probiotics and the gut microbiota in intestinal health and disease.

Authors:  Mélanie G Gareau; Philip M Sherman; W Allan Walker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-27       Impact factor: 46.802

10.  Auto-Contractive Maps: an artificial adaptive system for data mining. An application to Alzheimer disease.

Authors:  M Buscema; E Grossi; D Snowdon; P Antuono
Journal:  Curr Alzheimer Res       Date:  2008-10       Impact factor: 3.498

View more
  30 in total

Review 1.  Human Milk Microbiota: Transferring the Antibiotic Resistome to Infants.

Authors:  Lahari Das; Richa Virmani; Vishal Sharma; Deepti Rawat; Yogendra Singh
Journal:  Indian J Microbiol       Date:  2019-09-05       Impact factor: 2.461

2.  Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth.

Authors:  Katherine M Antosca; Diana A Chernikova; Courtney E Price; Kathryn L Ruoff; Kewei Li; Margaret F Guill; Natalie R Sontag; Hilary G Morrison; Shuyu Hao; Mitchell L Drumm; Todd A MacKenzie; Dana B Dorman; Lynn M Feenan; Molly A Williams; John Dessaint; Irene H Yuan; Brian J Aldrich; Lisa A Moulton; Lily Ting; Ana Martinez-Del Campo; Edward J Stewart; Margaret R Karagas; George A O'Toole; Juliette C Madan
Journal:  J Bacteriol       Date:  2019-07-24       Impact factor: 3.490

3.  The Profile of Human Milk Metabolome, Cytokines, and Antibodies in Inflammatory Bowel Diseases Versus Healthy Mothers, and Potential Impact on the Newborn.

Authors:  Xuanyi Meng; Garett Dunsmore; Petya Koleva; Yesmine Elloumi; Richard You Wu; Reed Taylor Sutton; Lindsy Ambrosio; Naomi Hotte; Vivian Nguyen; Karen L Madsen; Levinus A Dieleman; Hongbing Chen; Vivian Huang; Shokrollah Elahi
Journal:  J Crohns Colitis       Date:  2019-03-30       Impact factor: 9.071

4.  Non-Coding RNAs in Human Breast Milk: A Systematic Review.

Authors:  Lina Tingö; Emelie Ahlberg; Lovisa Johansson; Sindre Andre Pedersen; Konika Chawla; Pål Sætrom; Erika Cione; Melanie Rae Simpson
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

5.  Microbiome as an Immunological Modifier.

Authors:  Manoj Kumar; Parul Singh; Selvasankar Murugesan; Marie Vetizou; John McCulloch; Jonathan H Badger; Giorgio Trinchieri; Souhaila Al Khodor
Journal:  Methods Mol Biol       Date:  2020

6.  Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship.

Authors:  Balazs I Bodai; Therese E Nakata
Journal:  Perm J       Date:  2020

7.  Jejunal inflammatory cytokines, barrier proteins and microbiome-metabolome responses to early supplementary feeding of Bamei suckling piglets.

Authors:  Jipeng Jin; Jianlei Jia; Liping Zhang; Qian Chen; Xiaoyan Zhang; Weibo Sun; Cunming Ma; Fafang Xu; Shoujun Zhan; Limin Ma; Guihua Zhou; Qiaoxi Chen
Journal:  BMC Microbiol       Date:  2020-06-17       Impact factor: 3.605

Review 8.  Neonatal Immune System Ontogeny: The Role of Maternal Microbiota and Associated Factors. How Might the Non-Human Primate Model Enlighten the Path?

Authors:  Natalia Nunez; Louis Réot; Elisabeth Menu
Journal:  Vaccines (Basel)       Date:  2021-06-01

Review 9.  The Potential Effects of Probiotics and ω-3 Fatty Acids on Chronic Low-Grade Inflammation.

Authors:  Ashley N Hutchinson; Lina Tingö; Robert Jan Brummer
Journal:  Nutrients       Date:  2020-08-11       Impact factor: 5.717

10.  The effect of early probiotic exposure on the preterm infant gut microbiome development.

Authors:  Yan Hui; Birgitte Smith; Martin Steen Mortensen; Lukasz Krych; Søren J Sørensen; Gorm Greisen; Karen Angeliki Krogfelt; Dennis Sandris Nielsen
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.